Stocktoria
ENDONOVO THERAPEUTICS, INC. ENDV
ENDONOVO THERAPEUTICS, INC. financials (annual)
Bars are annual figures from 2013 to 2022; red bars are negative (a loss or cash outflow).
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $135,355 | $73,105 | $165,796 | $310,164 | $83,263 | — | — | $4,265 | $24,192 | $22,896 |
| Gross profit | $125,365 | $58,120 | $100,427 | $216,779 | $70,333 | — | — | $2,103 | $8,707 | $8,903 |
| R&D expense | — | $0 | $3,283 | $153,126 | $274,265 | $115,159 | $0 | — | — | — |
| Operating income | -$3.3M | -$2.2M | -$2.9M | -$3.8M | -$4.2M | -$4.6M | -$5.4M | -$2.6M | -$2.2M | -$2.4M |
| Interest expense | — | $941,566 | $2.1M | — | — | — | — | — | — | — |
| Income tax | — | — | — | — | — | — | — | $0 | $0 | $532 |
| Net income | -$18.5M | -$3.1M | -$395,584 | -$17.3M | -$6.4M | -$10.8M | -$5.3M | -$6.8M | -$959,494 | -$2.9M |
| Operating cash flow | -$678,838 | -$986,584 | -$741,590 | -$2.5M | -$2.9M | -$3.0M | -$2.5M | -$1.0M | -$909,296 | -$257,416 |
| Free cash flow | — | — | — | -$2.5M | -$2.9M | — | — | -$1.0M | -$909,296 | — |
| Cash & equivalents | $98 | $85,936 | $13,420 | $18,893 | $379,151 | $90,173 | $55,533 | $41,473 | $988 | $3,255 |
| Total assets | $1.3M | $2.0M | $2.6M | $3.3M | $4.2M | $4.6M | $318,679 | $409,363 | $45,589 | $73,593 |
| Total liabilities | $33.5M | $17.8M | $17.0M | $23.8M | $15.6M | $14.2M | $8.9M | $9.7M | $4.7M | $4.2M |
| Shareholders' equity | -$32.2M | -$15.8M | -$14.4M | -$20.5M | -$11.4M | -$9.6M | -$8.6M | -$9.3M | -$4.7M | -$4.1M |
Growth · year-over-year · Revenue CAGR 28.9%
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | +85.2% | -55.9% | -46.5% | +272.5% | — | — | — | -82.4% | +5.7% | -49.7% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2022-12-31. Facts plus Stocktoria's own computed scores — not investment advice.